Nebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2431
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Nebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial ; volume:15 ; number:1 ; day:10 ; month:9 ; year:2015 ; pages:1-8 ; date:12.2015
BMC pediatrics ; 15, Heft 1 (10.9.2015), 1-8, 12.2015
- Creator
-
Khanal, Aayush
- Contributor
-
Sharma, Arun
Basnet, Srijana
Sharma, Pushpa Raj
Gami, Fakir Chandra
SpringerLink (Online service)
- DOI
-
10.1186/s12887-015-0434-4
- URN
-
urn:nbn:de:1111-2016110919467
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Khanal, Aayush
- Sharma, Arun
- Basnet, Srijana
- Sharma, Pushpa Raj
- Gami, Fakir Chandra
- SpringerLink (Online service)
Other Objects (12)
The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
Hypertonic saline infusion for treating intracranial hypertension after severe traumatic brain injury
Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial
Exploring the efficacy of using hypertonic saline for nebulizing treatment in children with bronchiolitis: a meta-analysis of randomized controlled trials
Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial)
Comparison of hypertonic saline versus normal saline on cytokine profile during CABG
A randomized clinical trial to assess the effect of zinc and vitamin D supplementation in addition to hypertonic saline on treatment of acute bronchiolitis
No Benefit of 3% Hypertonic Saline Following Experimental Intracerebral Hemorrhage
Hypertonic saline induces inflammation in human macrophages through the NLRP1 inflammasome
Bronchiolitis
Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis
Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients
The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
Hypertonic saline infusion for treating intracranial hypertension after severe traumatic brain injury
Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial
Exploring the efficacy of using hypertonic saline for nebulizing treatment in children with bronchiolitis: a meta-analysis of randomized controlled trials
Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial)
Comparison of hypertonic saline versus normal saline on cytokine profile during CABG
A randomized clinical trial to assess the effect of zinc and vitamin D supplementation in addition to hypertonic saline on treatment of acute bronchiolitis
No Benefit of 3% Hypertonic Saline Following Experimental Intracerebral Hemorrhage
Hypertonic saline induces inflammation in human macrophages through the NLRP1 inflammasome
Bronchiolitis
Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis
Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients
The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
Hypertonic saline infusion for treating intracranial hypertension after severe traumatic brain injury
Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial
Exploring the efficacy of using hypertonic saline for nebulizing treatment in children with bronchiolitis: a meta-analysis of randomized controlled trials
Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial)
Comparison of hypertonic saline versus normal saline on cytokine profile during CABG
A randomized clinical trial to assess the effect of zinc and vitamin D supplementation in addition to hypertonic saline on treatment of acute bronchiolitis
No Benefit of 3% Hypertonic Saline Following Experimental Intracerebral Hemorrhage
Hypertonic saline induces inflammation in human macrophages through the NLRP1 inflammasome
Bronchiolitis
Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis